Literature DB >> 22476947

Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

J A Johnson1, B Carstensen, D Witte, S L Bowker, L Lipscombe, A G Renehan.   

Abstract

Substantial evidence suggests that people with type 2 diabetes have an increased risk of developing several types of cancers. These associations may be due to a number of direct and indirect mechanisms. Observational studies of these associations, including the potential role for glucose-lowering therapy, are being increasingly reported, but face a number of methodological challenges. This paper is the first of two review papers addressing methodological aspects underpinning the interpretations of links between diabetes and cancer, and suggests potential approaches to study designs to be considered in observational studies. This paper reviews factors related to cancer incidence in the diabetic population; the second paper relates to studies of cancer mortality.

Entities:  

Mesh:

Year:  2012        PMID: 22476947     DOI: 10.1007/s00125-012-2525-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  85 in total

1.  Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.

Authors:  Panagiotis N Papanikolaou; Georgia D Christidi; John P A Ioannidis
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

2.  Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study.

Authors:  M Wei; S P Gaskill; S M Haffner; M P Stern
Journal:  Obes Res       Date:  1997-01

3.  Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

Authors:  Anja Schienkiewitz; Matthias B Schulze; Kurt Hoffmann; Anja Kroke; Heiner Boeing
Journal:  Am J Clin Nutr       Date:  2006-08       Impact factor: 7.045

4.  Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.

Authors:  Mahvash Zakikhani; Ryan Dowling; I George Fantus; Nahum Sonenberg; Michael Pollak
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

5.  Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.

Authors:  J A Johnson; S L Bowker; K Richardson; C A Marra
Journal:  Diabetologia       Date:  2011-07-12       Impact factor: 10.122

6.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

Authors:  Susanna C Larsson; Nicola Orsini; Alicja Wolk
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

7.  Diabetes mellitus and ovarian cancer (Sweden).

Authors:  Elisabete Weiderpass; Weimin Ye; Harri Vainio; Rudolf Kaaks; Hans-Olov Adami
Journal:  Cancer Causes Control       Date:  2002-10       Impact factor: 2.506

8.  Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients.

Authors:  Edoardo Mannucci; Matteo Monami; Daniela Balzi; Barbara Cresci; Laura Pala; Cecilia Melani; Caterina Lamanna; Ilaria Bracali; Michela Bigiarini; Alessandro Barchielli; Niccolo Marchionni; Carlo Maria Rotella
Journal:  Diabetes Care       Date:  2010-06-14       Impact factor: 17.152

9.  Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

Authors:  Rangaswamy Govindarajan; Luke Ratnasinghe; Debra L Simmons; Eric R Siegel; Madhu V Midathada; Lawrence Kim; Peter J Kim; Randall J Owens; Nicholas P Lang
Journal:  J Clin Oncol       Date:  2007-04-20       Impact factor: 44.544

10.  Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research.

Authors:  Bruce B Duncan; Maria I Schmidt
Journal:  Diabetes Care       Date:  2009-09       Impact factor: 19.112

View more
  85 in total

Review 1.  The epidemiology of diabetes and cancer.

Authors:  Bendix Carstensen; Marit Eika Jørgensen; Søren Friis
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

2.  Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies.

Authors:  Baodong Yao; Hong Fang; Wanghong Xu; Yujie Yan; Huilin Xu; Yinan Liu; Miao Mo; Hua Zhang; Yanping Zhao
Journal:  Eur J Epidemiol       Date:  2014-01-05       Impact factor: 8.082

3.  Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment.

Authors:  Kristina Ranc; Marit E Jørgensen; Søren Friis; Bendix Carstensen
Journal:  Diabetologia       Date:  2014-03-15       Impact factor: 10.122

Review 4.  Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

Authors:  A G Renehan; H-C Yeh; J A Johnson; S H Wild; E A M Gale; H Møller
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

Review 5.  Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.

Authors:  Elisabetta Patorno; Amanda R Patrick; Elizabeth M Garry; Sebastian Schneeweiss; Victoria G Gillet; Dorothee B Bartels; Elvira Masso-Gonzalez; John D Seeger
Journal:  Diabetologia       Date:  2014-09-12       Impact factor: 10.122

6.  Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults.

Authors:  Peter T Campbell; Christina C Newton; Neal D Freedman; Jill Koshiol; Michael C Alavanja; Laura E Beane Freeman; Julie E Buring; Andrew T Chan; Dawn Q Chong; Mridul Datta; Mia M Gaudet; J Michael Gaziano; Edward L Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lindsey King; I-Min Lee; Martha S Linet; Julie R Palmer; Jessica L Petrick; Jenny N Poynter; Mark P Purdue; Kim Robien; Lynn Rosenberg; Vikrant V Sahasrabuddhe; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Victoria L Stevens; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Andrew G Renehan; Katherine A McGlynn
Journal:  Cancer Res       Date:  2016-10-15       Impact factor: 12.701

Review 7.  Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.

Authors:  Anne Blaes; Anna Prizment; Ryan J Koene; Suma Konety
Journal:  Heart Fail Clin       Date:  2017-04       Impact factor: 3.179

8.  Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies.

Authors:  Wu-jie Bu; Lei Song; Dan-yi Zhao; Bing Guo; Jing Liu
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

Review 9.  Diabetes mellitus and metformin in hepatocellular carcinoma.

Authors:  Koji Fujita; Hisakazu Iwama; Hisaaki Miyoshi; Joji Tani; Kyoko Oura; Tomoko Tadokoro; Teppei Sakamoto; Takako Nomura; Asahiro Morishita; Hirohito Yoneyama; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 10.  Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors:  Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.